Global Gene Expression Analysis Identifies Age-Related Differences in Knee Joint Transcriptome during the Development

Aimy Sebastian1, Deepa K Murugesh1, Melanie E Mendez1,2

  • 1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratories, Livermore, CA 94550, USA.

Insights

Aging exacerbates osteoarthritis (OA) development after injury. Older mice show more severe cartilage damage and bone changes due to heightened inflammation and reduced cartilage repair mechanisms following injury.

Area of Science:

  • Orthopedics
  • Molecular Biology
  • Gerontology

Background:

  • Osteoarthritis (OA) is a degenerative joint disease influenced by aging and injury.
  • The interplay between aging and injury in OA pathogenesis remains poorly understood.
  • Investigating age-related molecular alterations is crucial for understanding OA development.

Purpose of the Study:

  • To investigate age- and injury-related molecular changes in mouse knee joints contributing to OA.
  • To compare the impact of injury on young versus aged mice in a post-traumatic arthritis (PTOA) model.
  • To identify molecular mechanisms underlying differential PTOA severity in aging individuals.

Main Methods:

  • RNA sequencing (RNA-seq) to profile knee joint transcriptomes in mice of different ages (10, 62, and 95 weeks).
  • Non-invasive tibial compression injury model to induce post-traumatic arthritis (PTOA).
  • Assessment of structural and molecular changes six weeks post-injury.

Main Results:

  • Aging increased expression of inflammatory genes and decreased cartilage metabolism genes.
  • Older mice (62 weeks) exhibited significantly more cartilage degeneration and osteophyte formation post-injury compared to younger mice.
  • While transcriptional responses to injury were similar, older mice showed higher inflammatory cytokine activation and lower cartilage/bone metabolism gene expression.

Conclusions:

  • Aging significantly worsens PTOA severity by promoting inflammation and impairing cartilage repair.
  • Differential gene expression related to inflammation and metabolism in aging contributes to increased PTOA susceptibility.
  • Understanding these age-related molecular changes is key to developing targeted OA therapies.

Related Concept Videos